Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
8.33
|
8.84
|
8.35
|
8.35
|
8.79
|
8.79
|
|
|
60 576.63
|
240.00
|
|
8.84
|
8.30
|
8.28
|
8.45
|
8.29
|
|
|
89 600.80
|
335.00
|
|
8.76
|
8.37
|
8.15
|
8.42
|
8.42
|
|
|
17 265.61
|
132.00
|
|
8.76
|
8.13
|
8.13
|
8.29
|
8.15
|
|
|
29 465.04
|
159.00
|
8.08
|
8.82
|
8.41
|
8.01
|
8.50
|
8.01
|
|
|
50 898.84
|
100.00
|
|
8.76
|
8.48
|
8.22
|
8.51
|
8.22
|
|
|
41 341.78
|
81.00
|
8.02
|
9.04
|
7.95
|
7.95
|
8.88
|
8.50
|
|
|
95 965.40
|
143.00
|
7.41
|
9.56
|
8.06
|
7.96
|
8.08
|
7.96
|
|
|
104 842.94
|
124.00
|
8.05
|
25.00
|
8.25
|
8.09
|
8.26
|
8.10
|
|
|
51 200.57
|
87.00
|
|
|
8.80
|
8.36
|
8.82
|
8.36
|
|
|
29 103.78
|
55.00
|
Coya Therapeutics, Inc. operates as a clinical-stage biotechnology company. The Company focuses on treatments for frontotemporal dementia, parkinson's and alzheimer's disease, sclerosis, and autoimmune conditions. Coya Therapeutics serves patients and healthcare professionals in the United States.